The Visceral Fat Endocrine Signature refers to the unique and detrimental pattern of hormones and signaling molecules released by adipose tissue stored deep within the abdominal cavity, known as visceral fat. Unlike subcutaneous fat, visceral fat is highly metabolically active and acts as a dysfunctional endocrine organ, secreting pro-inflammatory adipokines and altering the body’s sensitivity to key metabolic hormones. This signature is a critical indicator of metabolic risk and systemic hormonal imbalance.
Origin
This concept originates from metabolic medicine and endocrinology, following the recognition that adipose tissue is not merely a storage depot but a dynamic endocrine organ. The term emphasizes the specific, negative hormonal profile associated with visceral fat accumulation. Research demonstrated that this fat depot’s location and its subsequent inflammatory output are more clinically relevant than overall body fat percentage.
Mechanism
The mechanism involves the chronic release of inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha, directly into the portal circulation, which leads to the liver. This inflammatory cascade disrupts hepatic insulin signaling, contributing to systemic insulin resistance. Furthermore, visceral fat alters the balance of adipokines like leptin and adiponectin, creating a state of hormonal dysregulation that perpetuates metabolic dysfunction and increases cardiovascular risk.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.